Trudeau, T., Prince, E., Chatain, O., Chee, K., Jackson, E., Limbrick, D., … Hankinson, T. (2022). THE USE OF NOVEL IN VITRO MODELS TO STUDY ADAMANTINOMATOUS CRANIOPHARYNGIOMA DISEASE BIOLOGY AND DRUG RESPONSE. In NEURO-ONCOLOGY (Vol. 24, pp. 15–15).

Trudeau, Tammy, Eric Prince, Oscar Chatain, Keanu Chee, Eric Jackson, David Limbrick, Robert Naftel, et al. “THE USE OF NOVEL IN VITRO MODELS TO STUDY ADAMANTINOMATOUS CRANIOPHARYNGIOMA DISEASE BIOLOGY AND DRUG RESPONSE.” In NEURO-ONCOLOGY, 24:15–15, 2022.

Trudeau T, Prince E, Chatain O, Chee K, Jackson E, Limbrick D, et al. THE USE OF NOVEL IN VITRO MODELS TO STUDY ADAMANTINOMATOUS CRANIOPHARYNGIOMA DISEASE BIOLOGY AND DRUG RESPONSE. In: NEURO-ONCOLOGY. 2022. p. 15–15.

Trudeau, Tammy, et al. “THE USE OF NOVEL IN VITRO MODELS TO STUDY ADAMANTINOMATOUS CRANIOPHARYNGIOMA DISEASE BIOLOGY AND DRUG RESPONSE.” NEURO-ONCOLOGY, vol. 24, 2022, pp. 15–15.

Trudeau T, Prince E, Chatain O, Chee K, Jackson E, Limbrick D, Naftel R, Feldstein N, Grant G, Ginn K, Niazi T, Smith A, Kilburn L, Chern J, Drapeau A, Lam S, Johnston J, Dudley R, Staulcup S, Hankinson T. THE USE OF NOVEL IN VITRO MODELS TO STUDY ADAMANTINOMATOUS CRANIOPHARYNGIOMA DISEASE BIOLOGY AND DRUG RESPONSE. NEURO-ONCOLOGY. 2022. p. 15–15.